Medicenna Therapeutics (MDNA) Competitors C$0.87 +0.04 (+4.82%) As of 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider TradesBuy This Stock MDNA vs. FRX, ITH, IPA, CRDL, APM, GXE, GPH, WMD, EQ, and SGWShould you be buying Medicenna Therapeutics stock or one of its competitors? The main competitors of Medicenna Therapeutics include Fennec Pharmaceuticals (FRX), International Tower Hill Mines (ITH), ImmunoPrecise Antibodies (IPA), Cardiol Therapeutics (CRDL), Andean Precious Metals (APM), Gear Energy (GXE), Graphite One (GPH), WeedMD (WMD), EQ (EQ), and Shoal Games (SGW). These companies are all part of the "pharmaceutical products" industry. Medicenna Therapeutics vs. Its Competitors Fennec Pharmaceuticals International Tower Hill Mines ImmunoPrecise Antibodies Cardiol Therapeutics Andean Precious Metals Gear Energy Graphite One WeedMD EQ Shoal Games Medicenna Therapeutics (TSE:MDNA) and Fennec Pharmaceuticals (TSE:FRX) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, valuation, institutional ownership, profitability and analyst recommendations. Is MDNA or FRX more profitable? Fennec Pharmaceuticals has a net margin of -2.30% compared to Medicenna Therapeutics' net margin of -533,640.00%. Fennec Pharmaceuticals' return on equity of 29.94% beat Medicenna Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Medicenna Therapeutics-533,640.00% -159.88% -32.80% Fennec Pharmaceuticals -2.30%29.94%8.88% Which has more risk and volatility, MDNA or FRX? Medicenna Therapeutics has a beta of 1.21, suggesting that its share price is 21% more volatile than the S&P 500. Comparatively, Fennec Pharmaceuticals has a beta of 0.25, suggesting that its share price is 75% less volatile than the S&P 500. Do insiders and institutionals have more ownership in MDNA or FRX? 13.0% of Medicenna Therapeutics shares are owned by institutional investors. Comparatively, 52.8% of Fennec Pharmaceuticals shares are owned by institutional investors. 22.6% of Medicenna Therapeutics shares are owned by insiders. Comparatively, 16.2% of Fennec Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has higher earnings and valuation, MDNA or FRX? Fennec Pharmaceuticals has higher revenue and earnings than Medicenna Therapeutics. Fennec Pharmaceuticals is trading at a lower price-to-earnings ratio than Medicenna Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMedicenna TherapeuticsC$4.87K13,369.74-C$25.98M-C$0.36-2.40Fennec PharmaceuticalsC$34.86M6.46-C$800.44K-C$0.06-197.69 Does the media prefer MDNA or FRX? In the previous week, Fennec Pharmaceuticals had 2 more articles in the media than Medicenna Therapeutics. MarketBeat recorded 2 mentions for Fennec Pharmaceuticals and 0 mentions for Medicenna Therapeutics. Fennec Pharmaceuticals' average media sentiment score of 0.30 beat Medicenna Therapeutics' score of 0.00 indicating that Fennec Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment Medicenna Therapeutics Neutral Fennec Pharmaceuticals Neutral Do analysts recommend MDNA or FRX? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Medicenna Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Fennec Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00 SummaryFennec Pharmaceuticals beats Medicenna Therapeutics on 11 of the 15 factors compared between the two stocks. Get Medicenna Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for MDNA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MDNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MDNA vs. The Competition Export to ExcelMetricMedicenna TherapeuticsBiotechnology IndustryMedical SectorTSE ExchangeMarket CapC$65.09MC$130.34MC$5.52BC$6.23BDividend YieldN/A3.74%4.25%6.72%P/E Ratio-2.403.5828.1554.79Price / Sales13,369.744,239.34438.321,148.37Price / Cash1.1513.1935.5383.29Price / Book3.3342.048.235.00Net Income-C$25.98M-C$92.15MC$3.23BC$301.20M7 Day Performance-1.14%0.80%-0.01%0.74%1 Month Performance-3.33%6.06%5.61%3.63%1 Year Performance-58.77%164.21%26.52%23.70% Medicenna Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MDNAMedicenna TherapeuticsN/AC$0.87+4.8%N/A-59.9%C$65.09MC$4.87K-2.4020Gap DownFRXFennec PharmaceuticalsN/AC$11.89+2.3%N/A+28.8%C$229.30MC$34.86M-201.4110Gap DownITHInternational Tower Hill MinesN/AC$1.30+1.6%N/A+110.0%C$182.52MN/A-54.31220News CoverageIPAImmunoPrecise AntibodiesN/AC$6.50+0.8%N/A+0.0%C$162.08MC$19.47M-7.3080Gap DownCRDLCardiol TherapeuticsN/AC$1.88-1.1%N/A-39.6%C$156MN/A-3.6920APMAndean Precious Metals2.3783 of 5 starsC$1.29+7.5%C$2.00+55.0%+29.0%C$135.47MC$154.78M2.5530GXEGear EnergyN/AN/AN/AN/AC$126.52MC$134.93M10.391,310GPHGraphite OneN/AC$0.68+3.0%N/A+3.0%C$68.85MN/A-9.7820News CoverageGap UpWMDWeedMDN/AC$0.28-1.8%N/A+0.0%C$67.82MC$27.53M-0.66628Gap UpEQEQN/AC$0.97flatN/A-18.3%C$67.51MC$9.70M-14.4840News CoverageGap DownSGWShoal GamesN/AC$0.50+42.9%N/A+0.0%C$65.56MC$106.98K-12.5040Gap Up Related Companies and Tools Related Companies Fennec Pharmaceuticals Alternatives International Tower Hill Mines Alternatives ImmunoPrecise Antibodies Alternatives Cardiol Therapeutics Alternatives Andean Precious Metals Alternatives Gear Energy Alternatives Graphite One Alternatives WeedMD Alternatives EQ Alternatives Shoal Games Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:MDNA) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medicenna Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medicenna Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MDNA Stock Alerts